M.a. Med Alliance S.a.
Clinical trials sponsored by M.a. Med Alliance S.a., explained in plain language.
-
New balloon aims to stop stents from failing again
Disease control OngoingThis study is testing a new type of drug-coated balloon to treat arteries that have narrowed again inside a previously placed stent, a condition called in-stent restenosis. About 418 participants will be randomly assigned to receive either the new balloon or a standard treatment,…
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Apr 04, 2026 01:34 UTC
-
Heart treatment showdown: balloon vs. stent in major trial
Disease control OngoingThis large international study compares two common treatments for clogged heart arteries. Over 3,300 patients with coronary artery disease will receive either a drug-coated balloon (which delivers medication and is often removed) or a permanent drug-eluting stent. The main goal i…
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New balloon treatment aims to keep leg arteries open
Disease control OngoingThis study is collecting real-world information on a drug-coated balloon used to treat blocked arteries in the legs, a condition called Peripheral Artery Disease (PAD). It will follow 723 patients for five years after their procedure to see how well the treatment works at keeping…
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New balloon aims to keep leg arteries open, prevent amputations
Disease control OngoingThis study is testing a new type of balloon coated with a drug (sirolimus) to see if it works better than a standard balloon at keeping leg arteries open. It involves 300 people with narrowed or blocked arteries in their upper leg, which can cause pain and difficulty walking. The…
Phase: NA • Sponsor: M.A. Med Alliance S.A. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC